Here’s an opportunity for a nice payday from one of my favorite speculative assets.
3 High-Growth Biotech Stocks Poised for Success in 2023
by
•With the opportunity for market-beating returns, here’s a large cap, mid-cap, and small-cap stock to consider.
This $4 Stock May Have Just Started a New Bullish Trend
by
•Here’s how to trade it with a target potential upside of 26%-45%.
The Bulls Are in Control of This Breakout Stock
by
•Our target potential upside is 16% to 29% in the next 3 to 6 months.
Upgrades and Downgrades for Tuesday, 4/18
by
•Here are today’s upgrades and downgrades: Nvidia, Comcast, Plug Power, First Solar, Chubb, Emerson Electric, Chubb and more.
These 2 Stocks Could Soar
by
•Looking to rebound, both could produce significant upside for shareholders in the next 12 months.
The Top 10 Stocks to Watch This Week for Possible Breakouts
by
•These names look poised for a possible breakout in the coming days.
This 7.8% Dividend is a Solid Buy Right Now
by
•A solid conservative play, with a strong portfolio and strategy that holds up well when volatility strikes makes it a great play if you’re worried about a recession.
This Stock Just Broke Out
by
•Our target potential upside is 21% to 42% in the next 3 to 6 months.
Upgrades and Downgrades for Monday, 4/17
by
•Here are today’s upgrades and downgrades: Meta Platforms, TSMC, Biogen, Enphase Energy, ConocoPhillips, Infosys, Ecolab and more.